Kasei Builds US Footprint with US$1.3 B Veloxis Buy

By Michelle Liu

Pharma Deals Review: Vol 2019 Issue 11 (Table of Contents)

Published: 28 Nov-2019

DOI: 10.3833/pdr.v2019.i11.2473     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

Asahi Kasei Pharma Denmark, a subsidiary of Asahi Kasei Corporation, has agreed to acquire Veloxis Pharmaceuticals in a deal worth DKK8...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details